Should I join a cancer clinical trial
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
- Last updated June 3, 2026. Informational only — not a substitute for your oncology team.
Should You Join a Cancer Clinical Trial?
This is an important decision that deserves careful thought. Let me help you understand the key considerations, then you can discuss this with your healthcare team.
The Basic Trade-Off: Standard Care vs. Clinical Trials
According to the NCCN Guidelines for Patients with Acute Lymphoblastic Leukemia, treatment decisions are very personal and should involve shared decision-making between you and your care team. Here's how to think about the choice:
Potential Advantages of Clinical Trials:
Enhanced Monitoring & Data
- You typically receive more frequent testing and imaging than standard treatment
- Your care team watches you more closely, which can catch changes early
- This intensive monitoring itself provides valuable information about how you're responding
Access to Newer Approaches
- You may get access to treatments not yet widely available
- You might receive standard-of-care treatment plus an experimental component, giving you "one more shot" at a good response
- For some cancers, clinical trials have led to FDA-approved treatments that became standard care
Contribution to Medical Knowledge
- Your participation helps researchers understand what works, potentially helping future patients
Potential Disadvantages:
Restrictions & Limitations
- You may not be able to use complementary treatments you want to try
- The trial has strict rules about what you can and cannot do
- You might be randomly assigned to a control group (standard treatment without the experimental component)
Time & Logistics
- More frequent visits and testing than standard care
- Travel requirements if the trial isn't local
- Additional time commitment
Uncertainty
- The experimental treatment may not work better than standard care
- Side effects may be unknown or different than expected
Key Questions to Ask Your Oncology Team
Before deciding, have an open conversation with your care team about:
-
"What is the standard treatment for my specific cancer, and how does this trial compare?"
- Understand what you'd get either way
-
"What is the experimental component of this trial, and what evidence suggests it might help?"
- Ask for preliminary data or research supporting the approach
-
"What are the inclusion and exclusion criteria, and do I qualify?"
- Make sure you actually meet the trial's requirements
-
"What monitoring and testing will I need, and how often?"
- Understand the time commitment and logistics
-
"What are the known and potential side effects?"
- Compare these to standard treatment side effects
-
"If the trial isn't working for me, can I stop and switch to standard treatment?"
- Understand your options if things aren't going well
-
"How will you determine if the treatment is working?"
- Ask about the specific measures they'll use
Getting a Second Opinion
According to the NCCN Guidelines, it's completely normal and encouraged to get a second opinion. Even doctors get second opinions! This is especially helpful when:
- You're considering a clinical trial
- You want another expert's perspective on whether a trial is right for you
- You want to understand all your options
Important Considerations for Your Situation
The NCCN Guidelines emphasize that your care team should include a multidisciplinary team (MDT) — experts from different backgrounds who know your cancer type well. When evaluating a trial, make sure:
- Your oncologist has reviewed the trial's details
- You understand how the trial fits with your overall treatment plan
- You feel comfortable with the research team running the trial
What Matters Most
Think about what's important to YOU:
- Your quality of life during treatment
- Access to the newest approaches
- Minimizing side effects
- Contributing to research
- Convenience and logistics
- Your goals for treatment (cure, extended survival, symptom management)
There is no single "right" answer. What works for one person may not be right for another. The key is making an informed decision that aligns with your values and goals.
Next Steps
- Ask your oncology team if there are clinical trials available for your specific cancer type and stage
- Request detailed information about any trials they recommend
- Consider getting a second opinion from another oncologist
- Take time to decide — while cancer can't be ignored, there is usually time to gather information and make a thoughtful choice
- Discuss your concerns openly with your care team
According to Cancer Patient Lab resources on clinical trials, your oncologist can help you understand which trials match your specific situation, including your previous treatments, current health status, and genetic/molecular profile of your cancer.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with clinical trials for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Prostate cancer, Gleason 6. Is active surveillance reasonable
TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona
What staging questions should I ask
TL;DR: Staging questions help your doctor understand how far your follicular lymphoma has spread, which directly determines your treatment options and
Just diagnosed with follicular lymphoma. What should I ask my oncologist
TL;DR: Follicular lymphoma is highly treatable, and your first conversation with your oncologist should focus on understanding your specific stage, wh
Prostate cancer, Gleason 6. Is active surveillance reasonable for me
TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona
What questions about staging should I bring up
TL;DR: Staging tells you how advanced your cancer is and helps your doctor plan treatment—ask your team to explain YOUR specific stage and what it mea
Just diagnosed with follicular lymphoma. What should I ask my oncologist at my first appointment
TL;DR: Your first appointment is about understanding your specific type of follicular lymphoma and what tests you need—ask your doctor what stage you
What lifestyle changes are recommended for cancer patients
TL;DR: Lifestyle changes like nutrition, exercise, sleep, and stress management can help support your body during cancer treatment and improve how you
What is the drug for fgfr mytation
Several FDA-approved drugs target FGFR mutations, with pemigatinib and infigratinib being the most commonly used; your doctor will choose based on you